• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含不同表面活性剂和固体分散体配方的颊黏附片的制霉菌素溶出度的增强。

Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation.

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, Damascus University, Syria.

出版信息

Arch Pharm Res. 2010 Nov;33(11):1771-9. doi: 10.1007/s12272-010-1109-1. Epub 2010 Nov 30.

DOI:10.1007/s12272-010-1109-1
PMID:21116780
Abstract

Nystatin is commonly employed to treat fungal infections in the mouth. It is not absorbed via the stomach and it will therefore not treat fungal infections in any part of the body other than the mouth. Nystatin buccoadhesive tablets release the drug very slowly due to the poor solubility of nystatin in water and also the presence of polymers with mucoadhesive properties. Therefore, the aim of the present study was to improve drug release from buccoadhesive tablets, while retaining adequate mucoadhesive properties. To this end, a solid dispersion of nystatin: lactose (1:3) was prepared and mixed with xanthan. The effects of hydrophilic surfactants such as cremophor RH40 and Tween 80 on drug release and mucoadhesive properties of nystatin tablets were also investigated as were swelling and erosion indices and strength of bioadhesion in vitro to a biological membrane. The interaction between nystatin and lactose in solid dispersion formulation was investigated by XRPD, FT-IR and DSC. The results showed that a solid dispersion formulation and mucoadhesive tablets containing surfactants led to faster drug release than their simple physical mixtures. Drug release was also faster from a solid dispersion compared to tablets containing surfactants. Swelling and erosion results showed that tablets made of a solid dispersion swelled and eroded faster than a physical mixture formulation. The presence of surfactant slightly increased the degree of swelling and erosion of buccoadhesive tablets.

摘要

制霉菌素通常用于治疗口腔真菌感染。它不会被胃吸收,因此不会治疗身体其他部位(口腔除外)的真菌感染。制霉菌素颊黏附片由于制霉菌素在水中的溶解度差以及具有黏膜黏附特性的聚合物的存在,药物释放非常缓慢。因此,本研究的目的是改善颊黏附片中药物的释放,同时保持足够的黏膜黏附特性。为此,制备了制霉菌素:乳糖(1:3)的固体分散体,并与黄原胶混合。还研究了亲水性表面活性剂如 Cremophor RH40 和吐温 80 对制霉菌素片剂的药物释放和黏膜黏附特性的影响,以及体外对生物膜的膨胀和侵蚀指数和生物黏附强度。通过 X 射线粉末衍射(XRPD)、傅里叶变换红外光谱(FT-IR)和差示扫描量热法(DSC)研究了固体分散体制剂中制霉菌素与乳糖之间的相互作用。结果表明,与简单的物理混合物相比,含有表面活性剂的固体分散体制剂和黏膜黏附片导致药物释放更快。与含有表面活性剂的片剂相比,固体分散体的药物释放也更快。膨胀和侵蚀结果表明,固体分散体片剂的膨胀和侵蚀速度快于物理混合物制剂。表面活性剂的存在略微增加了颊黏附片的溶胀和侵蚀程度。

相似文献

1
Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation.含不同表面活性剂和固体分散体配方的颊黏附片的制霉菌素溶出度的增强。
Arch Pharm Res. 2010 Nov;33(11):1771-9. doi: 10.1007/s12272-010-1109-1. Epub 2010 Nov 30.
2
Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets.使用黄原胶及其与合成聚合物的二元混合物来设计口腔粘附性制霉菌素片剂的控释制剂。
Pharm Dev Technol. 2010 Jul-Aug;15(4):360-8. doi: 10.3109/10837450903246416.
3
Double-layered mucoadhesive tablets containing nystatin.含制霉菌素的双层粘膜粘附片
AAPS PharmSciTech. 2002;3(3):E22. doi: 10.1208/pt030322.
4
Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation.新型抗真菌黏膜黏附膜的设计。第二部分。制剂与体外生物药剂学评价。
Int J Pharm. 2007 May 24;336(2):263-8. doi: 10.1016/j.ijpharm.2006.12.001. Epub 2006 Dec 6.
5
Formulation, characterization and in vitro evaluation of antifungal activity of Nystatin micro emulsion for topical application.用于局部应用的制霉菌素微乳剂的配方、表征及体外抗真菌活性评价
Pak J Pharm Sci. 2019 Jul;32(4):1671-1677.
6
Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system.卡波姆的药物释放:具有用作黏膜黏附药物递送系统潜在用途的卡波姆钠盐基质。
Int J Pharm. 2004 May 19;276(1-2):59-66. doi: 10.1016/j.ijpharm.2004.02.006.
7
Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.制霉菌素黏膜黏附性阴道给药系统的研发及体外评价
J Pharm Sci. 2009 Feb;98(2):555-64. doi: 10.1002/jps.21457.
8
Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance.用于治疗口腔念珠菌病的新型粘膜粘附缓释片:生物药剂学性能的“体内”评价
J Pharm Sci. 2009 May;98(5):1871-6. doi: 10.1002/jps.21513.
9
Formulation and in vitro evaluation of prednisolone buccoadhesive tablets.泼尼松龙口腔黏附片的制剂与体外评价
Farmaco. 2005 Apr;60(4):339-44. doi: 10.1016/j.farmac.2005.01.009.
10
In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.阿魏酸钠从基于Compritol 888 ATO的骨架片中的体外控释
Int J Pharm. 2006 Nov 6;324(2):152-7. doi: 10.1016/j.ijpharm.2006.06.006. Epub 2006 Jun 9.

引用本文的文献

1
Chlorhexidine Mucoadhesive Buccal Tablets: The Impact of Formulation Design on Drug Delivery and Release Kinetics Using Conventional and Novel Dissolution Methods.洗必泰粘膜粘附口腔片:使用传统和新型溶出方法的制剂设计对药物递送和释放动力学的影响。
Pharmaceuticals (Basel). 2021 May 23;14(6):493. doi: 10.3390/ph14060493.
2
Development of a Solid Dispersion of Nystatin with Maltodextrin as a Carrier Agent: Improvements in Antifungal Efficacy against spp. Biofilm Infections.以麦芽糊精为载体的制霉菌素固体分散体的研制:提高对 spp. 生物膜感染的抗真菌疗效。
Pharmaceuticals (Basel). 2021 Apr 22;14(5):397. doi: 10.3390/ph14050397.